Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
Data on the treatment of sarcoidosis-associated pulmonary hypertension are scarce, while the variety of underlying pathophysiologic mechanisms are a major limitation in the implementation of a universal therapy. We report a 47-year-old male patient who presented with stage II sarcoidosis and associa...
Saved in:
Published in | Therapeutic advances in respiratory disease Vol. 3; no. 3; pp. 99 - 101 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.06.2009
SAGE PUBLICATIONS, INC SAGE Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!